Authors:
Wiszniewski, W
Fondaneche, MC
Le Deist, FO
Kanariou, M
Selz, FO
Brousse, N
Steimle, V
Barbieri, G
Alcaide-Loridan, C
Charron, D
Fischer, A
Lisowska-Grospierre, B
Citation: W. Wiszniewski et al., Mutation in the class II trans-activator leading to a mild immunodeficiency, J IMMUNOL, 167(3), 2001, pp. 1787-1794
Authors:
Deffrennes, V
Vedrenne, J
Stolzenberg, MC
Piskurich, J
Barbieri, G
Ting, JP
Charron, D
Alcaide-Loridan, C
Citation: V. Deffrennes et al., Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter, J IMMUNOL, 167(1), 2001, pp. 98-106
Authors:
Lennon-Dumenil, AM
Barbouche, MR
Vedrenne, J
Prod'Homme, T
Bejaoui, M
Ghariani, S
Charron, D
Fellous, M
Dellagi, K
Alcaide-Loridan, C
Citation: Am. Lennon-dumenil et al., Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHCclass II deficiency, J IMMUNOL, 166(9), 2001, pp. 5681-5687
Authors:
Peijnenburg, A
Van den Berg, R
Van Eggermond, MJCA
Sanal, O
Vossen, JMJJ
Lennon, AM
Alcaide-Loridan, C
Van den Elsen, PJ
Citation: A. Peijnenburg et al., Defective MHC class II expression in an MHC class II deficiency patient iscaused by a novel deletion of a splice donor site in the MHC class II transactivator gene, IMMUNOGENET, 51(1), 2000, pp. 42-49